The management of panic disorder

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 14, 2002, Pages 17-21

  Sheehan, David V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; IBUPROFEN; IMIPRAMINE; NORDAZEPAM; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGORAPHOBIA; ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; HUMAN; HYPERALGESIA; ORTHOSTATIC HYPOTENSION; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; TREATMENT PLANNING; WEIGHT GAIN; WITHDRAWAL SYNDROME;

ALPRAZOLAM; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZODIAZEPINES; CLINICAL TRIALS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; MONOAMINE OXIDASE INHIBITORS; PANIC DISORDER; PATIENT COMPLIANCE; PHENELZINE; PLACEBOS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0036913495     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Sheehan DV, Coleman JH, Greenblatt DJ, et al. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. J Clin Psychopharmacol 1984;4:66-75
2. Sheehan DV, Raj AB, Hamett-Sheehan K, et al. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: A double-blind placebo-controlled study. Acta Psychiatr Scand 1993;88: 1-11
3. Klerman GL. Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 1988;45:407-412
4. Ballenger JC, Burrows GD, DuPont RL, et al. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial, 1: Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422
5. Cross-National Collaborative Panic Study, second phase investigators. Drug treatment of panic disorder: Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 1992;160:191-202
6. Otto MW, Tuby KS, Gould RA, et al. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001;158:1989-1992
7. Sheehan DV. Why sustained-release medications? Practical considerations in the management of patients with anxiety. Psychiatr Ann 1993;23 (10, suppl):3-6
8. Pecknold J, Luthe L, Munjack D, et al. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder. J Clin Psychopharmacol 1994;14:314-321
9. Schweizer E, Patterson W, Rickels K, et al. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Am J Psychiatry 1993;150: 1210-1215
10. Holland LH, Musch BC, Hindmarch I. Specific effects of benzodiazepines and tricyclic antidepressants in panic disorder: Comparisons of clomipramine with alprazolam SR and adinazolam SR. Hum Psychopharmacol Clin Exp 1999;14:119-124
11. Michelson D, Lydiard RB, Pollack MH, et al. Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo. Am J Psychiatry 1998;155: 1570-1577
12. Perna G, Bertani A, Caldirola D, et al. A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study. Pharmacopsychiatry 2001;34:85-90
13. Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998;155:36-42
14. Asnis GM, Hameedi FA, Goddard AW, et al. Fluvoxamine in the treatment of panic disorder: A multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res 2001;103:1-14
15. Pollack MH, Otto MW, Worthington JJ, et al. Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial. Arch Gen Psychiatry 1998; 55:1010-1016
16. den Boer JA. Pharmacotherapy of panic disorder: Differential efficacy from a clinical viewpoint. J Clin Psychiatry 1998;59(suppl 8):30-36
17. Rickels K, Schweizer E. Panic disorder: Long-term pharmacotherapy and discontinuation. J Clin Psychopharmacol 1998;18(suppl 2):12S-18S
18. Goddard AW, Brouette T, Almai A, et al. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001;58: 681-686